Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Morimoto (Tokyo, Japan), K. Izumi (Tokyo, Japan), M. Ato (Tokyo, Japan), S. Mitarai (Tokyo, Japan), N. Hasegawa (Tokyo, Japan). Actual treatment practices of pulmonary nontuberculous mycobacteriosis analysed from national insurance claim data in Japan. 347

Member's Comments

No comment yet.

Related content which might interest you: The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada Source: Eur Respir J 2011; 37: 1158-1165 Year: 2011 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020 Cross-border management of tuberculosis cases through an updated ERS/WHO TB consilium Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Intrahospital mortality of tuberculosis – our experience of national tuberculosis program implementation Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006 The impact of national recommendations on antibiotic treatment of community acquired pneumonia. Do pediatricians follow the national guidelines? Source: International Congress 2017 – Pulmonary infection and inflammation Year: 2017 Effectiveness of TB diagnostics with microbiological methods in TB service and general health care institutions Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011 Trend of delay treatment of patient and healthcare system in diagnosis and management of pulmonary tuberculosis in Iran Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018 Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice Source: Eur Respir J 2016; 48: 1571-1581 Year: 2016 Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017 Lithuanian national tuberculosis manual Source: Eur Respir J 2002; 20: Suppl. 38, 546s Year: 2002 The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis Source: Eur Respir J 2016; 48: 963-971 Year: 2016 Population based survey on the NTM pulmonary disease treatment in Japan Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Latent tuberculosis among health care workers in Denmark estimated by IGRA Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Protection of healthcare workers against transmission of Mycobacterium tuberculosis in hospitals: a review of the evidence Source: ERJ Open Res, 6 (1) 00317-2019; 10.1183/23120541.00317-2019 Year: 2020 Influence of age, sex and hospitalisation on the administration of tuberculosis medication: an evaluation of routine data from a German health insurer Source: ERJ Open Res, 6 (3) 00369-2019; 10.1183/23120541.00369-2019 Year: 2020 Schoolchildren from a private school whose teacher had bacillary pulmonary tuberculosis. Case management and control Source: Eur Respir J 2002; 20: Suppl. 38, 164s Year: 2002 Predictors of retrospective tuberculosis treatment outcomes in selected health institutions in Nigeria Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021